ROMATSA, however, has funds only for a few weeks, so the Romanian government may look to legislative amendments that would allow the continuation of operations, according to News.ro. "ROMATSA has made a proposal whereby legislation would be changed through a legislative amendment, which could be discussed next week in Parliament. On June 30, 2026, ROMATSA was notified by Eurocontrol regarding the establishment of a precautionary-executory garnishment measure within enforcement proceedings initiated by Pfizer Romania against the Romanian state. The claimed amount is RON 3.42 billion (principal balance and interest), to which recovery costs of EUR 18.5 million are added. According to the court statement, Romania has to pay approximately EUR 600 million of the total sum, about 0.2% of its GDP.